Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

Purified Anti-Mouse CD161/NK1.1 Antibody[PK136], Functional Grade

Product Sizes
100 ug
£89.00
E-AB-F09870-100UG
1 mg
£171.00
E-AB-F09870-1MG
5 mg
£490.00
E-AB-F09870-5MG
25 mg
£1515.00
E-AB-F09870-25MG
50 mg
£2247.00
E-AB-F09870-50MG
100 mg
£3211.00
E-AB-F09870-100MG
About this Product
SKU:
E-AB-F09870
Additional Names:
CD161 antigen-like family member C,CD161/NK1.1,CD161c,Killer cell lectin-like receptor subfamily B member 1C,Klrb1c,Ly-55c,NKR-P1 40,NKR-P1.9,NKR-P1C
Application:
Depletion, Flow Cytometry
Buffer:
Sterile PBS, pH 7.2. < 1.0 EU per mg of the antibody as determined by the LAL method.
translate.label.attr.clone:
PK136
Clonality:
Monoclonal
Concentration:
>= 1 mg/ml
Extra Details:
NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-G Gamma production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers. None (Azide-Free,Low Endotoxin) are perfectly suited to be used in culture or in vivo (for nonhuman studies) for functional assays blocking, neutralizing, activation or depletion where the presence of azide may damage cells or exogenous endotoxin may signal or activate cells.
Host:
Mouse
Immunogen:
Recombinant Mouse NK1.1 protein
Isotype:
IgG2a, kappa
Purity:
>98%
Purification:
protein a/g purified
Reactivities:
Mouse
Shipping Conditions:
Blue Ice
Storage Conditions:
2-8[o]C Avoid freeze/thaw cycles., -20[o]C Avoid freeze/thaw cycles.
Supplier:
Elabscience
Type:
Antibody: Monoclonal Antibody
C57/BL6 Mouse splenocytes were stained with 0.2 ug APC conjugated Anti-Mouse NK1.1 Antibody[PK136], Functional Grade (Right) and 0.2 ug APC conjugated Mouse IgG2a, K Kappa Isotype Control (Left), followed by anti-Mouse CD49b PE-conjugated Monoclonal Antibody.
MCF-7 were stained with 0.2 ug Purified Anti-Human CD340 Antibody[chA21] (Right) and 0.2 ug Mouse IgG2a, K Kappa Isotype Control (Left), followed by FITC-conjugated Goat Anti-Mouse IgG Secondary Antibody.
C57/BL6 Mouse splenocytes were stained with 0.2 ug Purified Anti-Mouse CD1d Antibody[1B1] (Right) and 0.2 ug Rat IgG2b, K Kappa Isotype Control (Left), followed by Elab Fluor® 647-conjugated Goat Anti-Rat IgG Secondary Antibody.
Human peripheral blood lymphocytes were stained with 0.2 ug Purified Anti-Human CD38 Antibody[AT13/5] (Right) and 0.2 ug Mouse IgG1, K Kappa Isotype Control (Left), followed by APC-conjugated Goat Anti-Mouse IgG Secondary Antibody, then anti-Human CD19 FITC-conjugated Monoclonal Antibody.
Human peripheral blood lymphocytes were stained with 0.2 ug Purified Anti-Human CD7 Antibody[3A1e] (Right) and 0.2 ug Mouse IgG2b, K Kappa Isotype Control (Left), followed by Elab Fluor® 647-conjugated Goat Anti-Mouse IgG Secondary Antibody, then anti-Human CD4 FITC-conjugated Monoclonal Antibody.